{
    "clinical_study": {
        "@rank": "117792", 
        "arm_group": [
            {
                "arm_group_label": "Second generation immigrants from high TB incidence countries", 
                "arm_group_type": "Other", 
                "description": "Answering the study Questionnaire and blood sampling for Interferon gamma release assay (IGRA)."
            }, 
            {
                "arm_group_label": "Native Israelis", 
                "arm_group_type": "Other", 
                "description": "Answering the study Questionnaire and blood sampling for Interferon gamma release assay (IGRA)."
            }
        ], 
        "brief_summary": {
            "textblock": "The aim of study is to evaluate the prevalence of latent TB in second generation immigrants\n      from countries with high incidence of tuberculosis (above 20 of 100,000) compare to the\n      control native Israelis without a family member who was born in a country with high\n      incidence of tuberculosis. Using study questionnaire IGRA and tuberculin skin test the\n      investigators expect that the second generation immigrants group will have more positive\n      IGRA test than the control native group."
        }, 
        "brief_title": "Latent Tuberculosis in Second Generation Immigrants From High Risk Countries Compare to Low-risk Young Israeli Adults", 
        "completion_date": {
            "#text": "March 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Latent Tuberculosis", 
        "condition_browse": {
            "mesh_term": [
                "Tuberculosis", 
                "Latent Tuberculosis"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Age 18-25\n\n          -  Men and women\n\n          -  Second generation immigrants from countries with high incidence of tuberculosis\n             (above 20 of 100,000).\n\n          -  Native Israelis without a family member who was born in a country with high incidence\n             of tuberculosis.\n\n        Exclusion Criteria:\n\n          -  Prior contact with a tuberculosis patient\n\n          -  Working (more than a month) in high risk setting such as health care workers, working\n             with immigrants from countries with high incidence of tuberculosis.\n\n          -  HIV infection and any immunodeficiency condition.\n\n          -  Recent live-virus vaccination\n\n          -  Acute infectious disease\n\n          -  Prior serious reaction to tuberculin skin test\n\n          -  Pregnancy"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "25 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "200", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 25, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02073669", 
            "org_study_id": "SHEBA-13-0668-DS-CTIL"
        }, 
        "intervention": {
            "arm_group_label": [
                "Second generation immigrants from high TB incidence countries", 
                "Native Israelis"
            ], 
            "intervention_name": "Answering the study Questionnaire and blood sampling for Interferon gamma release assay (IGRA)", 
            "intervention_type": "Procedure"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Interferon-gamma", 
                "Interferons"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "latent tuberculosis", 
            "tuberculin skin test", 
            "Interferon gamma release assay", 
            "immigration"
        ], 
        "lastchanged_date": "February 26, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Ramat Gan", 
                    "country": "Israel", 
                    "zip": "52621"
                }, 
                "name": "Sheba Medical Center"
            }
        }, 
        "location_countries": {
            "country": "Israel"
        }, 
        "number_of_arms": "2", 
        "official_title": "Better Identification of Latent Tuberculosis Infection Among Israeli Young Adults by Comparison Skin Tests and Interferon Gamma Releasing Assays (IGRA)", 
        "overall_contact": {
            "email": "dekel.shlomi@sheba.health.gov.il", 
            "last_name": "Dekel Shlomi, M.D.", 
            "phone": "972-3-5302339"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Israel: Ministry of Health", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "March 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Interferon gamma release assay ( IGRA)", 
            "safety_issue": "No", 
            "time_frame": "Up to 3 months after tuberculin skin test"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02073669"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Sheba Medical Center", 
        "sponsors": {
            "collaborator": {
                "agency": "Tel Aviv Lung Association", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Sheba Medical Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2014", 
        "study_design": "Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator), Primary Purpose: Diagnostic", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}